AYTU BIOPHARMA, INC (AYTU)
Nasdaq · Pharmaceutical Preparations · Inc. DE
What they're doing
Not enough recent activity to summarise.
Signals, last 12 months
- Material 8-K filingFiled 8-K disclosing material agreement
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-10-03 | PYSZCZYMUKA GREG | officer | A | 12,500 | 0 | $0 |
| 2025-10-03 | Disbrow Jarrett | officer | A | 12,500 | 0 | $0 |
| 2025-10-03 | Disbrow Jarrett | officer | A | 19,606 | 0 | $0 |
| 2025-10-03 | Selhorn Ryan J | officer | A | 16,243 | 0 | $0 |
| 2025-10-03 | Selhorn Ryan J | officer | A | 17,500 | 0 | $0 |
| 2025-10-03 | Disbrow Joshua R. | director | A | 31,446 | 0 | $0 |
| 2025-10-03 | Disbrow Joshua R. | director | A | 22,500 | 0 | $0 |
| 2025-10-03 | LIU VIVIAN H | director | A | 10,000 | 0 | $0 |
| 2025-10-03 | JAIN ABHINAV | director | A | 10,000 | 0 | $0 |
| 2025-10-03 | DOCKERY CARL | director | A | 10,000 | 0 | $0 |
| 2025-10-03 | Donofrio John Jr. | director | A | 10,000 | 0 | $0 |
| 2025-06-09 | Disbrow Jarrett | officer | P | 16,666 | 1.5 | $24,999 |
| 2025-06-09 | Disbrow Joshua R. | officer | P | 66,666 | 1.5 | $99,999 |
| 2025-03-31 | PYSZCZYMUKA GREG | officer | M | 209 | — | — |
| 2025-02-28 | Disbrow Joshua R. | officer | P | 15,000 | 1.3 | $19,500 |
| 2025-02-05 | Selhorn Ryan J | officer | M | 105 | — | — |
| 2024-12-31 | PYSZCZYMUKA GREG | officer | M | 208 | — | — |
| 2024-11-11 | Selhorn Ryan J | officer | A | 14,000 | 0 | $0 |
| 2024-11-06 | LIU VIVIAN H | director | A | 1,500 | 0 | $0 |
| 2024-11-06 | JAIN ABHINAV | director | A | 1,500 | 0 | $0 |
| 2024-11-06 | Donofrio John Jr. | director | A | 1,500 | 0 | $0 |
| 2024-11-06 | DOCKERY CARL | director | A | 1,500 | 0 | $0 |
| 2024-09-30 | PYSZCZYMUKA GREG | officer | M | 209 | — | — |
| 2024-06-30 | PYSZCZYMUKA GREG | officer | M | 208 | — | — |
| 2023-08-11 | LIU VIVIAN H | director | A | 1,500 | 0 | $0 |
| 2020-12-30 | DOCKERY CARL | director | S | 209 | 6.01 | $1,256 |
| 2020-11-18 | DOCKERY CARL | director | P | 10,000 | 0.92 | $9,200 |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.
Recent filings
- 2026-09-22 8-K
- 2026-09-22 10-K
- 2026-08-14 SCHEDULE 13G/A
- 2026-07-30 4
- 2026-07-30 4
- 2026-07-30 4
- 2026-07-30 4
- 2026-07-30 4
- 2026-07-30 4
- 2026-07-30 4
- 2026-07-30 4
- 2026-06-25 8-K
- 2026-05-13 10-Q
- 2026-05-13 8-K
- 2026-04-02 8-K
- 2026-02-17 SCHEDULE 13G/A
- 2026-02-13 SCHEDULE 13G/A
- 2026-02-03 10-Q
- 2026-02-03 8-K
- 2026-01-20 8-K